跳至主要内容
临床试验/NCT06442527
NCT06442527撤回不适用

Using Virtual Reality Before Transcranial Magnetic Stimulation for the Treatment of OCD

Yale University2 个研究点 分布在 1 个国家目标入组 5 人开始时间: 2025年5月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
撤回
入组人数
5
试验地点
2
主要终点
Tolerability of VR treatment by qualitative assessment

研究概览

简要总结

This study will focus on the use of Virtual Reality (VR) technology in patients receiving treatment using Transcranial Magnetic Stimulation (TMS) for Obsessive-Compulsive Disorder (OCD)

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Participants must be at least 18 years old
  • Patients must have been clinically evaluated by a Yale Interventional Psychiatry Service physician who has deemed them appropriate to receive TMS for the treatment of OCD
  • Ability and willingness, in the investigator's judgement, to comply with the study procedure and study requirements.

排除标准

  • Hearing or visual impairment to the degree that would interfere with ability to see or hear VR content.
  • Difficulty in understanding spoken or written English
  • Pregnancy
  • History of seizure disorder
  • Unable to provide informed consent
  • Dementia or other cognitive disorder or intellectual disability that would impair the subject's ability to understand the study procedure (per investigator judgment)
  • Any implanted medical device, risk of interference with which by the VR device in the investigator's judgment can put patient at additional undue risk.
  • Any other medical or psychiatric comorbidity that the investigator judges would put the participant at additional undue risk due to study participation or would impair subject's ability to participate in the study.
  • Was previously enrolled/randomized into the study

研究组 & 干预措施

Treatment Group

Experimental

This single arm will include all participants of the study, who will all receive the intervention

干预措施: Virtual Reality (Device)

结局指标

主要结局

Tolerability of VR treatment by qualitative assessment

时间窗: Within 1 hour after each treatment session

Tolerability will be assessed by open-ended interview of the patient about their experience and any difficulty tolerating VR

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验